Suchergebnisse - "Ferro, Antonella"

PubPharm (5)

1

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy : Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Guarneri, V. | Giorgi, C. | Cinieri, S. | +23

2

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3) : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von De Placido, S. | Gallo, C. | De Laurentiis, M. | +128

CommentIn: Lancet Oncol. 2018 Apr;19(4):431-432. - PMID 29482984

3

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer : the MITO-2 randomized phase III trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Pignata, S. | Scambia, G. | Ferrandina, G. | +27

4

Diagnostic value of automated Her2 evaluation in breast cancer : a study on 272 equivocal (score 2+) Her2 immunoreactive cases using an FDA approved system

enthalten in: Applied immunohistochemistry & molecular morphology : AIMM | 2011

von Cantaloni, C. | Tonini R, E. | Eccher, C. | +10

5

Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2010

von Murgia, V. | Sorio, R. | Griso, C. | +7

1
[1]